CLINICAL_TRIALS trial_result · 2020-04-01

Clinical Trial Update: A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD) [Phase 1]

A Phase 1 pilot study evaluating riluzole in patients with post-traumatic stress disorder has completed and results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Yale University | Conditions: PTSD | Phase 1 | Status: COMPLETED | Results posted: 2020-04-01